Zobrazeno 1 - 10
of 176
pro vyhledávání: '"GE, Raskob"'
Autor:
JN George, SH Woolf, GE Raskob, JS Wasser, LM Aledort, PJ Ballem, VS Blanchette, JB Bussel, DB Cines, JG Kelton, AE Lichtin, R McMillan, JA Okerbloom, DH Regan, I Warrier
Publikováno v:
Blood. 88:3-40
Publikováno v:
Blood. 85:3034-3039
Factor VII is an independent risk factor for ischemic heart disease. We performed a prospective study to evaluate the effect of combined low-dose warfarin-aspirin on activated factor VII (factor VIIa) and to determine if abruptly stopping this treatm
Publikováno v:
In Annals of Emergency Medicine July 2000 36(1):86-86
Autor:
Lanting VR; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands., Takada T; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of General Medicine, Shirakawa Satellite for Teaching and Research (STAR), Fukushima Medical University, Fukushima, Japan., Bosch FTM; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands., Marshall A; Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom., Grosso MA; Clinical Development, Daiichi Sankyo, Basking Ridge, New Jersey, United States., Young AM; Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom.; Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Lee AYY; Division of Hematology, University of British Columbia, British Columbia Cancer Agency, Vancouver BC, Canada., Di Nisio M; Department of Medicine and Ageing Sciences, Gabriele D'Annunzio University, Chieti, Italy., Raskob GE; University of Oklahoma Health Sciences Center and OU Health, Oklahoma City, Oklahoma, United States., Kamphuisen PW; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands., Büller HR; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., van Es N; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.
Autor:
Wang TF; Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Canada., Khorana AA; Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Foundation, Cleveland, OH, USA., Agnelli G; Internal Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy., Bloomfield D; Anthos Therapeutics, Cambridge, MA, USA., Bonaca MP; Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.; CPC Clinical Research, Aurora, CO, USA., Büller HR; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Connors JM; Hematology Division, Brigham and Women's Hospital, Boston, MA, USA., Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan., Jing ZC; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Kakkar AK; Thrombosis Research Institute, London, UK., Khder Y; Anthos Therapeutics, Cambridge, MA, USA., Raskob GE; Hudson College of Public Health University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Soff GA; General Hematology Service, University of Miami Health System/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Verhamme P; Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, KU Leuven, Leuven, Belgium., Weitz JI; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada., Carrier M; Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Canada.
Publikováno v:
The oncologist [Oncologist] 2023 Jul 05; Vol. 28 (7), pp. 555-564.
Autor:
Raskob GE; University of Oklahoma Health Sciences Center, Oklahoma City.
Publikováno v:
NEJM evidence [NEJM Evid] 2023 Jul; Vol. 2 (7), pp. EVIDe2300106. Date of Electronic Publication: 2023 Jun 27.
Autor:
de Winter MA; Department of Acute Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CX Utrecht, The Netherlands., Büller HR; Department of Vascular Medicine, Amsterdam UMC, Meibergdreef 9 1105 AZ Amsterdam, The Netherlands., Carrier M; Department of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, 501 Smyth Rd, K1H8L6 Ottawa, Ontario, Canada., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' Hospitals, King's College London, Westminster Bridge Road, London, SE1 7EH, UK., Hansen JB; Thrombosis Research Center (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, 9037, Tromsø and Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, 9038, Tromsø, Norway., Kaasjager KAH; Department of Acute Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CX Utrecht, The Netherlands., Kakkar AK; Thrombosis Research Institute London, 1B Manresa Road Chelsea, SW3 6LR, London, UK., Middeldorp S; Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands., Raskob GE; Hudson College of Public Health, University of Oklahoma Health Sciences Center, 801 N.E. 13th Street, Oklahoma City, OK 73104, USA., Sørensen HT; Department of Clinical Medicine - Department of Clinical Epidemiology, Olof Palmes Allé 43-45, 8200 Aarhus N, Denmark., Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands., Wells PS; Department of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, 501 Smyth Rd, K1H8L6 Ottawa, Ontario, Canada., Dorresteijn JAN; Department of Vascular Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands., Nijkeuter M; Department of Acute Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CX Utrecht, The Netherlands.
Publikováno v:
European heart journal [Eur Heart J] 2023 Apr 07; Vol. 44 (14), pp. 1231-1244.
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.
Autor:
de Winter MA; Department of Acute Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Uijl A; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, the Netherlands; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, the Netherlands; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Büller HR; Department of Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Carrier M; Department of Medicine, University of Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' Hospitals, King's College London, London, UK., Hansen JB; Thrombosis Research Center, Department of Clinical Medicine, UiT - The Arctic University of Norway and University Hospital of North Norway, Tromsø, Norway., Kaasjager KHAH; Department of Acute Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Kakkar AK; Thrombosis research Institute, London, UK., Middeldorp S; Department of Internal Medicine & Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Raskob GE; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Sørensen HT; Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark., Wells PS; Department of Medicine, University of Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Nijkeuter M; Department of Acute Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Dorresteijn JAN; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: J.A.N.Dorresteijn-2@umcutrecht.nl.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Mar; Vol. 21 (3), pp. 573-585. Date of Electronic Publication: 2022 Dec 22.
Autor:
Raskob GE; Hudson College of Public Health University of Oklahoma Health Sciences Center Oklahoma City OK., Ageno W; Department of Medicine and Surgery University of Insubria Varese Italy., Albers G; Stanford Stroke Center Stanford University Medical Center Stanford CA., Elliott CG; Department of Medicine Intermountain Medical Center and the University of Utah Salt Lake City UT., Halperin J; The Cardiovascular Institute Mount Sinai Medical Center New York NY., Maynard G; University of California, Davis Sacramento CA., Steg PG; Universite Paris-Cite Assistance Publique-Hôpitauxde Paris, and INSERM U-1148 Paris France.; Imperial College, Royal Brompton Hospital London United Kingdom., Weitz JI; McMaster University and the Thrombosis and Atherosclerosis Research Institute Hamilton Ontario Canada., Albanese J; Janssen Research & Development, LLC Raritan NJ., Yuan Z; Janssen Research & Development, LLC Titusville NJ., Levitan B; Janssen Research & Development, LLC Titusville NJ., Lu W; Janssen Research & Development, LLC Raritan NJ., Suh EY; Janssen Research & Development, LLC Raritan NJ., Spiro T; Clinical Development Pharmaceuticals, Bayer U.S. LLC Whippany NJ., Lipardi C; Janssen Research & Development, LLC Raritan NJ., Barnathan ES; Janssen Research & Development, LLC Raritan NJ., Spyropoulos AC; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell The Feinstein Institute for Medical Research, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services Northwell Health at Lennox Hill Hospital New York NY.
Publikováno v:
Journal of the American Heart Association [J Am Heart Assoc] 2022 Oct 18; Vol. 11 (20), pp. e026229. Date of Electronic Publication: 2022 Oct 07.
Autor:
Spyropoulos AC; Department of Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, Manhasset, New York, United States.; Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, New York, United States., Raskob GE; Hudson College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States., Spiro TE; Clinical Development, Pharmaceuticals, Bayer US LLC, Whippany, New Jersey, United States., Lu W; Janssen Research & Development, LLC, Raritan, New Jersey, United States., De Sanctis Y; Clinical Development, Pharmaceuticals, Bayer US LLC, Whippany, New Jersey, United States., Albanese J; Janssen Research & Development, LLC, Raritan, New Jersey, United States., Mebazaa A; Department of Anesthesia and Critical Care, University of Paris, Paris, France., Barnathan ES; Janssen Research & Development, LLC, Raritan, New Jersey, United States.
Publikováno v:
TH open : companion journal to thrombosis and haemostasis [TH Open] 2022 Oct 07; Vol. 6 (4), pp. e304-e308. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).